By Memorandum Order entered by The Honorable Sue L. Robinson in In Re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, Civil Action No. 09-MD-2118-SLR (D.Del., May 20, 2011), the Court granted plaintiffs Eurand, Inc. and Anesta AG’s motion for temporary restraining order and enjoined defendants Mylan Pharmaceuticals, Inc. and Mylan, Inc. (collectively, “Mylan”) from manufacturing, using, offering to sell, or selling generic extended release cyclobenzaprine products.

A complete copy of the Memorandum Opinion is attached hereto.